ÇϹæ¾ÈÁø¿¡ ´ëÇÑ 4-AminopyridineÀÇ ¾ïÁ¦ È¿°ú
Suppression of Downbeat Nystagmus with 4-Aminopyridine

´ëÇѾȽŰæÀÇÇÐȸÁö 2014³â 4±Ç 1È£ p.33 ~ p.35

±è¼ºÈñ(Kim Sung-Hee) - ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ½Å°æ°úÇб³½Ç
±èÁö¼ö(Kim Ji-Soo) - ¼­¿ï´ëÇб³ Àǰú´ëÇÐ ½Å°æ°úÇб³½Ç

Abstract

We determined the effect of 4-aminopyridine (4-AP) on slow phase velocity (SPV) of downbeat nystagmus in a patient with idiopathic cerebellar dysfunction. The downbeat nystagmus had a linear slow phase and increased during downward gaze, convergence, and straight head hanging. In contrast, the downbeat nystagmus was suppressed during upward gaze, and was not affected by visual fixation and lateral gazes. Ninety minutes after administration of 10 mg 4-AP, mean SPV of downbeat nystagmus decreased from 3.0 to 1.2O/s during attempted primary gaze and from 3.3 to 0.4O/s during downward gaze. As a potassium channel blocker, 4-AP appears to reduce the spontaneous upward ocular drift in downbeat nystagmus.

Ű¿öµå

4-aminopyridine, Downbeat nystagmus
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå